The document discusses the marketing plan for a new drug called Wiloxin created by Wilson Pharmaceuticals Pakistan Ltd. It outlines the drug's composition and usage. It analyzes the market feasibility, consumer demand and estimated profits in Rawalpindi and Islamabad. It also discusses the government policies around drug availability, pricing and quality control that the company's plan will follow. Finally, it lists the various advertising mediums that will be used to promote Wiloxin.

2. COMMITEE MEMBERS THAWBAN BAIG MARKETING MANAGER WAQAR HANIF MARKET RESEARCHER AYSHA SHAHID CONSUMER RESEARCHER UMER AHMED LEGAL ADVISOR

3. WILOXIN, A REVOLUTIONARY MEDICINE

4. WELCOME TO THE MARKETING DEPARTMENT OF WILSONS PHARMACEUTICALS PAKISTAN LTD .

5. TABLE OF CONTENTS INTRODUCTION MARKET FEASIBILITY CONSUMER DEMAND GOVERNMENT POLICIES ADVERTISEMENT PLAN

6. INTRODUCTION PROBLEM PERCENTAGE OF PATIENTS WHERE WILOXIN STANDS…?

7. INTRODUCTION COMPOSITION OF WILOXIN (CLARITHROMYCIN + OFLAOXACIN) USAGE

8. WARNING WILOXIN IS "PREGNANCY CATEGORY C" MEDICATIONS, INDICATING THAT NO STUDIES HAVE BEEN CONDUCTED TO ASSESS THE SAFETY OF THIS DRUG FOR PREGNANT WOMEN. NO SAFETY PROBLEMS HAVE BEEN IDENTIFIED FOR USE OF THIS TYPE OF MEDICATIONS FOR PREGNANT WOMEN HOWEVER, BECAUSE OF THE UNKNOWN EFFECTS OF THIS DRUG ON PREGNANT WOMEN AND INFANTS WHO WERE EXPOSED BEFORE BIRTH, THESE DRUGS SHOULD BE USED DURING PREGNANCY ONLY IF THE POTENTIAL BENEFIT JUSTIFIES THE POTENTIAL RISK TO THE UNBORN CHILD.

9. MARKET FEASIBILITY ANALYSES

10. MARKET FEASIBILITY ANALYSIS SCOPE OF PRODUCT COST COMMON ILLNESS WIDE MARKET

11. MARKET FEASIBILITY ANALYSIS MARKET ANALYSIS S# BRAND NAME PACK SIZE COMPANY NAME PRICE (RS) 1 WILOXIN 250 MG TAB 1X10'S WILSON PHARMA 99 2 KLARICIDN 250 MG TAB 1X10'S ABBOT 296 3 CLARION 250 MG TAB 1X10'S FEROZSONS 186 4 CLARITEK 250 MG TAB 1X10'S GETZ 323 1 WILOXIN 500 MG TAB 1X10'S WILSON PHARMA 310 2 KLARICIDN 500 MG TAB 1X10'S ABBOT 648 3 CLARION 500 MG TAB 1X10'S FEROZSONS 432 4 CLARITEK 500 MG TAB 1X10'S GETZ 571

12. MARKET FEASIBILITY ANALYSIS TARGET MARKETS RAWALPINDI AND ISLAMABAD HIGH POLLEN COUNT ALL AGE GROUP MARKET POTENTIAL TOTAL POULATION POLLEN ENERGY PATIENT HUGE MARKET

13. CONSUMER DEMAND AND PROFIT

14. CONSUMER DEMAND AND PROFIT POPULATION OF RAWALPINDI AND ISLAMABAD (4.41 MILLION AND 1.74 MILLION) TARGET AREA GOLDEN PERIOD OF SALES

15. CONSUMER DEMAND AND PROFIT ALLERGY AND INFLUENZA PATIENTS ESTIMATED CONSUMER DEMAND IN RAWALPINDI ESTIMATED CONSUMER DEMAND IN ISLAMABAD ESTIMATED PROFIT

16. GOVERNMENT POLICIES AND OUR PLAN

17. GOVERNMENT POLICIES TO ENSURE AVAILABILITY OF SAFE, EFFECTIVE AND QUALITY PRODUCT THE DRUG ACT 1976 SYSTEM OF LICENCING TQM

18. GOVERNMENT POLICIES CHEAP PRODUCT LOCAL EQUIPMENT TAX FREE EQUIPMENT PRICE BASED UPON QUALITY

19. GOVERNMENT POLICIES RESTRICTION ON MIS-USING PROMOTE CONCEPT OF RATIONAL USE OF MEDICINE SALE WITHOUT DOCTOR’S PERSCRIPTION IS RESTRICTED LEGALLY CANCELLATION OF LICENCE

20. GOVERNMENT POLICIES AVAILABILITY OF DRUGS WILSONS MEDICINE STOCK STORES WILSONS SALE POINTS SUPPLY ISSUE

21. GOVERNMENT POLICIES AVAILABILITY OF INGREDIENTS PURCHASE OF INGREDIENTS IN BULK FREE FROM HURDLES MAINTAIN THE INGREDIENT QUALITY

22. GOVERNMENT POLICIES AVOIDING MANUFACTURING SUBSTANDARD MEDICINES TESTING OF INGREDIENTS RIGHT OF HEALTH MINISTRY WILSON HAS LATEST LABORATORIES

23. ADVERTISEMENT PLAN

24. ADVERTISEMENT PLAN MEDIUMS USED FOR ADVERTISEMENT TELEVISION NEWSPAPERS RADIO SIGN BOARDS BROCHERS WALLPAPERS NOTE PADS, PENS AND GIFTS

25. ADVERTISEMENT PLAN VIDEO